Hey Mangoman. This has been brought up before on these very...

Hey Mangoman. This has been brought up before on these very pages.

May I refer you to the above link Chel6888 posted. Go to the trial Objective and read:
"To evaluate the efficacy and safety of pentosian polysulphate sodium (PPS, Elmiron (R) ) for dyslipidaemia and knee osteoarthritis related symptoms". The study originally started in 2022.

Registration number

ACTRN12621000654853

Ethics application status

Approved

Date submitted

25/02/2021

Date registered

31/05/2021

Date last updated

2/05/2022

Date data sharing statement initially provided

31/05/2021

Elmiron has also been discussed here as well. As a reminder, Elmiron, (then J+J's drug) proved to be hazardous to nearly everyone's eyes who took it all year long for years. I can't believe that they are still having trials on this drug. BUT.....in this business, who knows when and where Lady Luck will strike.
PAR has no patents or agreement with Bene to trial or market the
oral version of PPS, because.................we have something that works and apparently causes no side effects. Darn the luck.